期刊文献+

多西紫杉醇联合顺铂同步放疗治疗食管癌术后局部淋巴结转移的临床观察 被引量:5

原文传递
导出
摘要 目的 探讨食管癌术后局部淋巴结转移放疗同时给予多西紫杉醇联合顺铂的疗效。方法 51例食管鳞状细胞癌手术后淋巴结复发转移患者,给予三维适形放射治疗,总剂量60~64 Gy,中位剂量62 Gy。放疗开始后1周内给予第1个周期化疗,多西紫杉醇75 mg/m2,顺铂75 mg/m2,每3周为1个疗程。放疗期间按周期常规进行化疗,放疗结束后根据肿瘤消退情况继续给予上述方案化疗2~4个周期。结果 全组患者总有效率82.4 %(42/51);中位无进展生存期为8.6个月,中位生存期为13.0个月;1、2、3年总生存率分别为51.0 %、18.6 %、6.2 %。不良反应主要表现为骨髓抑制和消化道反应,其次为放射性肺炎和放射性食管炎。结论 多西紫杉醇联合顺铂化疗配合放疗治疗食管癌术后局部淋巴结转移,可有效控制区域外淋巴结转移病变,提高了局部区域淋巴结的控制率并延长生存期。
出处 《肿瘤研究与临床》 CAS 2013年第8期561-562,共2页 Cancer Research and Clinic
  • 相关文献

参考文献6

二级参考文献39

共引文献77

同被引文献80

  • 1汤忠祝,朱远,邓清华,王建,马胜林.Ⅲ期非小细胞肺癌后程大分割三维适形放疗疗效分析[J].中华放射肿瘤学杂志,2007,16(4):250-253. 被引量:6
  • 2Neri B, Pantaleo P, Glommoni E, et al. Oxaliplatin, 5-fluorouracil/leu- covorin and epirubicin as first-line treatment in advanced gastric carci- now.a: a phase Ⅱ study[J]. Br J Cancer,2007,96(7) : 1043-1046.
  • 3Kim S, Lim DH, Lee J, et al. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarci- noma of the stomach [ J ]. Int J Radiat Oncol Biol Phys, 2005,63 ( 5 ) : 1279-1285.
  • 4Noronha V,Prabhash K,Bhosale B,et al.AOS28 High pathological response rate with docetaxel plus cisplatin plus fluorouracil induction regimen in oesophageal cancer:Initial experience[J].European Journal of Cancer,2012,48(4):S13.
  • 5Nguyen NP,Krafft SP,Hung VV,et al.Feasibility of tomotherapy to reduce normal lung and cardiac toxicity for distal esophageal cancer compared to three-dimensional radiotherapy[J].Radiotherapy and Oncology,2011,101(3):438-442.
  • 6Enestvedt BK,Ginsberg GG.Advances in endoluminal therapy for esophageal cancer[J].Gastrointestinal Endoscopy Clinics of North America,2013,23(1):17-39.
  • 7Therasse P,Arbuck SG,Eisenhauer ET. New guidelines to evaluate the response to treament in solid tumors[J].J Nat Cancer lnst,2000,(03):205-216.
  • 8Jonak C,Raderer M,Zacherl J. The combination of 5-fluorouracil, leukovorin, etoposide, and cisplatin(FLEP)in patients with metastatic esophageal cancer. A single-institution experience[J].Anticancer Research,2008,(6B):4101-4104.
  • 9Amdal CD,Jacobsen AB,Guren MG,Bjordal K. Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer:a systematic review[J].ACTA ONCOLOGICA,2013,(04):679-690.
  • 10Ku GY,Ilson DH. Chemotherapeutic options for gastroesophageal junction tumors[J].Seminars in Radiation Oncology,2013,(01):24-30.

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部